(Q48291216)

10 February 2018

title

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma (English)

1 reference

10 February 2018

main subject

nervous system

0 references

author

Montserrat Rué i Monné

8

1 reference

10 February 2018

Susan M Domchek

2

Susan M Domchek

1 reference

10 February 2018

3

Harold J Burstein

1 reference

10 February 2018

Eric Winer

10

Eric Winer

1 reference

10 February 2018

Irene Kuter

6

Irene Kuter

1 reference

10 February 2018

Jerry Younger

5

Jerry Younger

1 reference

10 February 2018

author name string

Johanna C Bendell

1

1 reference

10 February 2018

Lyndsay Harris

4

1 reference

10 February 2018

Craig Bunnell

7

1 reference

10 February 2018

Rebecca Gelman

9

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 June 2003

1 reference

10 February 2018

published in

Cancer

1 reference

10 February 2018

volume

97

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

page(s)

2972-2977

1 reference

10 February 2018

HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

The platinum agents: a role in breast cancer treatment?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

The natural history of breast cancer patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Central nervous system metastasis from breast carcinoma. Autopsy study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Breast carcinoma: Pattern of metastasis at autopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Experiences with metastatic neoplasms involving the spinal cord

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Leptomeningeal spread of breast cancer: Report of case and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11436

1 reference

7 January 2021

Radiation therapy in the management of brain metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Molecular prognostic factors for breast cancer metastasis and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11436

7 January 2021

Identifiers

DOI

10.1002/CNCR.11436

1 reference

10 February 2018

release_xhe2m4busva5pjrmoszl5gwuhq

Fatcat ID

0 references

1 reference

10 February 2018